167 related articles for article (PubMed ID: 6231317)
1. Hydralazine-induced systemic lupus erythematosus presenting as pyoderma gangrenosum-like ulcers.
Peterson LL
J Am Acad Dermatol; 1984 Feb; 10(2 Pt 2):379-84. PubMed ID: 6231317
[TBL] [Abstract][Full Text] [Related]
2. Severe hydralazine-induced lupus presenting as systemic lupus erythematosus.
Rubin RL; Haluptzok RF; Davila LM
Lupus; 2020 Apr; 29(5):509-513. PubMed ID: 32041503
[TBL] [Abstract][Full Text] [Related]
3. Hydralazine-induced lupus erythematosus-like syndrome.
Irias JJ
Am J Dis Child; 1975 Jul; 129(7):862-4. PubMed ID: 50009
[TBL] [Abstract][Full Text] [Related]
4. Lymphocytotoxic antibodies in hydralazine-induced lupus erythematosus.
Ryan PF; Hughes GR; Bernstein R; Mansilla R; Dollery CT
Lancet; 1979 Dec; 2(8154):1248-9. PubMed ID: 92663
[No Abstract] [Full Text] [Related]
5. Sweet syndrome associated with hydralazine-induced lupus erythematosus.
Cartee TV; Chen SC
Cutis; 2012 Mar; 89(3):121-4. PubMed ID: 22530328
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to the five histones and poly(adenosine diphosphate-ribose) in drug induced lupus: implications for pathogenesis.
Hobbs RN; Clayton AL; Bernstein RM
Ann Rheum Dis; 1987 May; 46(5):408-16. PubMed ID: 2884934
[TBL] [Abstract][Full Text] [Related]
7. Hydralazine, antinuclear antibodies, and the lupus syndrome.
Mansilla-Tinoco R; Harland SJ; Ryan PJ; Bernstein RM; Dollery CT; Hughes GR; Bulpitt CJ; Morgan A; Jones JM
Br Med J (Clin Res Ed); 1982 Mar; 284(6320):936-9. PubMed ID: 6802356
[TBL] [Abstract][Full Text] [Related]
8. Immune responses to hydralazine and nuclear antigens in hydralazine-induced lupus erythematosus.
Hahn BH; Sharp GC; Irvin WS; Kantor OS; Gardner CA; Bagby MK; Perry HM; Osterland CK
Ann Intern Med; 1972 Mar; 76(3):365-74. PubMed ID: 4536922
[No Abstract] [Full Text] [Related]
9. Antiguanosine antibodies: a new marker for procainamide-induced systemic lupus erythematosus.
Weisbart RH; Yee WS; Colburn KK; Whang SH; Heng MK; Boucek RJ
Ann Intern Med; 1986 Mar; 104(3):310-3. PubMed ID: 3511820
[TBL] [Abstract][Full Text] [Related]
10. Antinuclear antibodies following hydralazine toxicity.
Condemi JJ; Moore-Jones D; Vaughan JH; Perry HM
N Engl J Med; 1967 Mar; 276(9):486-91. PubMed ID: 4959828
[No Abstract] [Full Text] [Related]
11. Hydralazine antinuclear antibodies and the lupus syndrome.
Ramsay LE; Silas J; Freestone S
Br Med J (Clin Res Ed); 1982 Jun; 284(6330):1711. PubMed ID: 6805676
[No Abstract] [Full Text] [Related]
12. Cardiac tamponade in hydrallazine-induced systemic lupus erythematosus.
Aylward PE; Tonkin AM; Bune A
Aust N Z J Med; 1982 Oct; 12(5):546-7. PubMed ID: 6960881
[No Abstract] [Full Text] [Related]
13. Hydralazine and lupus nephritis.
Ihle BU; Whitworth JA; Dowling JP; Kincaid-Smith P
Clin Nephrol; 1984 Nov; 22(5):230-8. PubMed ID: 6240359
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of immunologic effects of hydralazine in hypertensive patients.
Litwin A; Adams LE; Zimmer H; Foad B; Loggie JH; Hess EV
Clin Pharmacol Ther; 1981 Apr; 29(4):447-56. PubMed ID: 6970646
[TBL] [Abstract][Full Text] [Related]
15. Hydralazine sensitivity: clinical features, autoantibody changes and HLA-DR phenotype.
Russell GI; Bing RF; Jones JA; Thurston H; Swales JD
Q J Med; 1987 Oct; 65(246):845-52. PubMed ID: 3329739
[TBL] [Abstract][Full Text] [Related]
16. A Case of Seronegative ANA Hydralazine-Induced Lupus Presenting With Pericardial Effusion and Pleural Effusion.
Elkholy KO; Akhtar H; Chakraborti A
Cureus; 2020 Aug; 12(8):e9831. PubMed ID: 32953340
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of immune response to hydralazine and development of antideoxyribonucleoprotein in patients receiving hydralazine.
Carpenter JR; McDuffie FC; Sheps SG; Spiekerman RE; Brumfield H; King R
Am J Med; 1980 Sep; 69(3):395-400. PubMed ID: 6968159
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced lupus: clinical and serological studies.
Harmon CE; Portanova JP
Clin Rheum Dis; 1982 Apr; 8(1):121-35. PubMed ID: 6811188
[No Abstract] [Full Text] [Related]
19. Hypotensive agents, beta-blockers, and drug-induced lupus.
Hughes GR
Br Med J (Clin Res Ed); 1982 May; 284(6326):1358-9. PubMed ID: 6122487
[No Abstract] [Full Text] [Related]
20. Hydralazine therapy in hypertensive patients with idiopathic systemic lupus erythematosus.
Reza MJ; Dornfeld L; Goldberg LS
Arthritis Rheum; 1975; 18(4):335-8. PubMed ID: 50845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
